Navigation Links
Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
Date:10/24/2007

PALO ALTO, Calif., Oct. 24 /PRNewswire/ -- Vivo Ventures, a venture capital firm specializing in life science investments, today announced that James Huang will join the firm as an Executive in Residence. With his extensive business development and operating experience, Mr. Huang will work with Vivo's portfolio companies while enhancing the firm's presence in Asia.

"We are excited about James coming on board and what he will be able to bring to Vivo," said Frank Kung, Managing Partner of Vivo Ventures. "His extensive relationships throughout the pharmaceutical industry, his impressive track record in closing multiple business development partnerships, and his experience in building companies make him a valuable asset to our team and our portfolio companies."

"Vivo Ventures is one of the best recognized life sciences venture firms in the U.S. and in Asia. I am very enthused about the opportunity to contribute to the success of Vivo's existing and future portfolio companies," commented James Huang.

About James Huang

With 20 years of experience in the pharmaceutical industry, James joins Vivo from Anesiva, where he has served as president since September 2005. Previously, he had served as Anesiva's senior vice president of business development and commercial operations.

He joined Anesiva from Tularik Inc., where he held the position of vice president of business development and commercial operations and led the development and negotiation of commercial and scientific collaborations, alliances, and licensing agreements. Among the most notable include: a collaboration with Medarex to develop and commercialize human therapeutic antibodies; a collaboration with Sankyo to jointly discover and develop human therapeutics related to orphan G-protein coupled receptors (GPCRs); as well as other technology collaborations and corporate development acquisitions. Mr. Huang also guided strategic planning and execution for Tularik's marketing progr
'/>"/>

SOURCE Vivo Ventures
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Tech companies get commerce loans for new ventures
2. Conference will focus on financing of early-stage ventures
3. Badger Ventures plans to fund IT; partisan stem-cell battle; BadgerNet draws fire
4. New Madison VC firm Badger Ventures looks for next big IT entrepreneurs
5. WARF expands license agreement with Advanced Cell Technology
6. Verizon expands broadband service in Wisconsin
7. Bandwidth provider expands in Milwaukee
8. Wisconsins biodiesel network expands
9. Quad/Graphics expands reach in western states
10. University of South Florida expands GE Healthcare relationship
11. Metavante expands healthcare payments division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2008)...UVER, July 3 / OncoGenex Technologies...S ) announced today that the companies,have amende...ependently,develop its lead cancer drug OGX-011. U...sponsible for all future development activities,c...Isis will no longer be,responsible for funding 35%...
(Date:7/3/2008)...N, Calif., July 3 /- AMDL, ...maceuticals headquartered in Tustin,Ca., with ope...nounced,today it has released its investor present...y,s website at http://www.amdl.com ., About AMDL...l company. The company is,headquartered in Tustin,...
(Date:7/2/2008)...CE V, Only Drug Eluting Stent to Demonstrate Super...s, Now Available in United States for ... PARK, Ill., July 2 /- Abbo...inistration (FDA) approved the,XIENCE(TM) V Everol...nt of,coronary artery disease. XIENCE V is the onl...
(Date:7/2/2008)...SE, Fla., July 2 /- Biohear...t is focused on the development of,autologous (pat...reatment,of chronic and acute heart damage, today ...p Index after the Russell Investment Group reconst...uity indexes on June 27, 2008., According to the ...
Breaking Biology Technology:OncoGenex increases economic interest in lead cancer drug OGX-011 2OncoGenex increases economic interest in lead cancer drug OGX-011 3OncoGenex increases economic interest in lead cancer drug OGX-011 4AMDL Announces Investor Relations Presentation Available on Website 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 2FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 3FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 4FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent 5Bioheart, Inc., Added to Russell Microcap Index 2
...ported in the June 2005 issue of the Harvard Busin...dominant. But many companies, even in people busin...ses they need to excel. While organizations have p...ital investments, suppliers and the production and... managing people seriously lag. , ,In their articl...
...a Middleton-based University of Wisconsin spin-off...ent on "stabilized hydroxyvitamin D" that will ext...patent, which will expire in 2021, covers the comp...idism in chronic kidney disease patients, as well ...currently working to complete. , ,Bone Care uses b...
...Thursday,s Digital Healthcare Conference in Madi...re facing plenty of them. , ,In today,s issue, the...g from the Digital Healthcare Conference, you,ll r...organizations face, and how they are approaching t... double challenges of liability and public scrutin...
...ted as regional director for Region 5 of Health an...resentative of HHS Secretary Michael Leavitt, hand...esota, Michigan and Ohio. , ,OBrien is the former ... also served as the director of public affairs for...also worked with the Illinois Department of Centra...
Other Biology Technology:Four steps to making talent management a core competence 2Four steps to making talent management a core competence 3Four steps to making talent management a core competence 4The tough choices facing health care 2The tough choices facing health care 3
(Date:7/3/2008)...of such marine creatures as clams, sand dollars an... million years ago with no clear trend afterwards,.... This contradicts previous work showing dramatic ...shed light on future diversity. , "Some of the t...happening today from global warming," says Jocelyn...
(Date:7/3/2008)...ion canal would seem a healthier place for toads t...University of Florida scientists have found the op...for a longstanding debate over whether agricultura...ists have found that toads in suburban areas are l...rmalities than toads near farms where some had bo...
(Date:7/3/2008)...rtris, a GlaxoSmithKline company focused on discov... diseases of aging such as Type 2 Diabetes, is inc...,s online edition of Cell Metabolism that mice t...ratrol showed an overall health improvement, inclu...s and cardiovascular dysfunction, and improved bal...
(Date:7/3/2008)...y consumers yet their properties have been difficu...ing a drain on our limited natural resources. Unti...l Laboratory (NPL) are working towards producing t...rceive naturalness. The results could help make sy... by our senses as being fully equivalent to the ,r...
Breaking Biology News(10 mins):Species have come and gone at different rates than previously believed 2Species have come and gone at different rates than previously believed 3New study points to agriculture in frog sexual abnormalities 2New study points to agriculture in frog sexual abnormalities 3Long-term study of middle-aged mice shows 2Long-term study of middle-aged mice shows 3Scientists set out to measure how we perceive naturalness 2Scientists set out to measure how we perceive naturalness 3Was it good for you too 3F 22775 1Was it good for you too 3F 22775 2Late life remarriage 3A Stepfamilies make caring more complex 22770 1Late life remarriage 3A Stepfamilies make caring more complex 22770 2HighPoint Solutions Develops Novel Incentive Compensation Plan for New Benign Prostatic Hyperplasia 28BPH 29 Product 22764 1HighPoint Solutions Develops Novel Incentive Compensation Plan for New Benign Prostatic Hyperplasia 28BPH 29 Product 22764 2Stanford study 3A Bioenergy potential of reviving abandoned agricultural land 3761 1Stanford study 3A Bioenergy potential of reviving abandoned agricultural land 3761 2Stanford study 3A Bioenergy potential of reviving abandoned agricultural land 3761 3Stanford study 3A Bioenergy potential of reviving abandoned agricultural land 3761 4
...specially in medicine. From magnetic resonance ima...s of the body’s tissues and organs have become the...and make recommendations for effective treatment. ...ped at Kent State University will provide doctors ...edical images that are commonly used. This patent-...
...replace the tissue it sloughs off is controlled by...cal School published in the May 4 issue of Cell, h...generation process not only for skin, but for many...d urogenital tract. This master regulator of epith...lose relative to the well-known tumor-suppressing ...
...er researchers are ridding diabetic patients of th...th maggots. , Professor Andrew Boulton and his tea...c patients whose foot ulcers were contaminated wit...ean period of three weeks, much quicker than the 2..., Professor Boulton, who published the results in...
...al to test a revolutionary treatment for blindness...UCL (University College London). The trial, funded...kind and could have a significant impact on future...s adults and children who have a condition called ...e of inherited retinal degeneration. This disease ...
Other Biology News:Novel system developed to turn data into real-time, interactive 3-D images 2Master regulatory gene of epithelial stem cells identified 2Maggots rid patients of MRSA 2First clinical trial of gene therapy for childhood blindness 2
Custom siRNA, HPLC purified, annealed from Ambion
Silencer Pre-designed siRNA, HPLC purified, annealed from Ambion
...rs are suitable for sizing linear double-stranded .... The 13 bands consist of 8.3- to 48.5-kb fragment...of Lambda DNA (cIind1ts857 Sam7). Ethidium bromide...sterisk (8271 bp 8612 bp 12220 bp and 19399 bp) to...
Immunogen: MBP-fusion protein of the C-terminal region of the a2 subunit (amino acids K581-D670) Storage: -20 C, Avoid Freeze/Thaw Cycles
Biology Products: